APA (7th ed.) Citation

Sriram Subramaniam, Stacy S. Shord, Ruby Leong, Kelly Norsworthy, Atiqur Rahman, Brian Booth, & Olanrewaju Okusanya. (2023). Study design considerations to assess the impact of potential drug-drug interactions in first‐in‐human studies in oncology drug development. Wiley.

Chicago Style (17th ed.) Citation

Sriram Subramaniam, Stacy S. Shord, Ruby Leong, Kelly Norsworthy, Atiqur Rahman, Brian Booth, and Olanrewaju Okusanya. Study Design Considerations to Assess the Impact of Potential Drug-drug Interactions in First‐in‐human Studies in Oncology Drug Development. Wiley, 2023.

MLA (9th ed.) Citation

Sriram Subramaniam, et al. Study Design Considerations to Assess the Impact of Potential Drug-drug Interactions in First‐in‐human Studies in Oncology Drug Development. Wiley, 2023.